Pub Date : 2025-10-01Epub Date: 2025-12-15DOI: 10.5005/jp-journals-10078-1498
Wesam Shamseldin Shalaby, Steven Lee Chang, Julia Yu, Teresa Horan, Sagar Shah, Shahin Hallaj, Marlene Moster, Reza Razeghinejad, Daniel Lee, Michael Pro, Aakriti Shukla, Ping Huang, Jonathan Myers, Tina Xia, Dilru Amarasekera
Aim and background: To compare postoperative intraocular pressure (IOP) spikes and 1-year surgical success among goniotomy procedures: Kahook Dual Blade (KDB), OMNI, bent ab interno needle goniotomy (BANG), and gonioscopy-assisted transluminal trabeculotomy (GATT).
Materials and methods: This single-center, retrospective chart review included glaucoma patients ≥18 years, who underwent goniotomy from January 2021 to December 2022 with ≥3 months of follow-up. Primary outcomes were IOP spikes (≥10 mm Hg increase within 3 months) and 12-month surgical success (≥20% IOP and/or ≥1 medication reduction without further surgery). Secondary outcomes included IOP and medication changes.
Results: Among 247 eyes (107 KDB, 63 OMNI, 77 BANG; all with phacoemulsification), IOP spikes occurred in 13.0% with no difference between groups (p = 0.900). Spikes were more common in severe glaucoma and associated with failure (p = 0.041), postoperative interventions (p <0.001), and reoperation (p = 0.026). At 12 months (n = 164), 68.9% achieved success with no difference between procedures (p = 0.972). Lower baseline IOP, open-angle glaucoma (OAG), and IOP spikes predicted failure. GATT eyes (n = 39, mostly standalone) had different baseline characteristics, were excluded from main analysis, but showed similar success (79.3%) with greater IOP and medication reduction.
Conclusion: Kahook Dual Blade, OMNI, and BANG with phacoemulsification had comparable 1-year safety and efficacy. IOP spikes increase the risk of failure and reoperation, especially in severe glaucoma. GATT showed favorable outcomes when performed standalone.
Clinical significance: Choice among KDB, OMNI, and BANG can be individualized without compromising outcomes. Monitoring for IOP spikes is crucial in high-risk eyes. Standalone GATT offers strong results when cataract surgery is not needed.
How to cite this article: Shalaby WS, Chang SL, Yu J, et al. Impact of Postoperative Intraocular Pressure Spikes on Outcomes Following Goniotomy: A Comparative Study of Surgical Techniques. J Curr Glaucoma Pract 2025;19(4):186-198.
{"title":"Impact of Postoperative Intraocular Pressure Spikes on Outcomes Following Goniotomy: A Comparative Study of Surgical Techniques.","authors":"Wesam Shamseldin Shalaby, Steven Lee Chang, Julia Yu, Teresa Horan, Sagar Shah, Shahin Hallaj, Marlene Moster, Reza Razeghinejad, Daniel Lee, Michael Pro, Aakriti Shukla, Ping Huang, Jonathan Myers, Tina Xia, Dilru Amarasekera","doi":"10.5005/jp-journals-10078-1498","DOIUrl":"10.5005/jp-journals-10078-1498","url":null,"abstract":"<p><strong>Aim and background: </strong>To compare postoperative intraocular pressure (IOP) spikes and 1-year surgical success among goniotomy procedures: Kahook Dual Blade (KDB), OMNI, bent <i>ab interno</i> needle goniotomy (BANG), and gonioscopy-assisted transluminal trabeculotomy (GATT).</p><p><strong>Materials and methods: </strong>This single-center, retrospective chart review included glaucoma patients ≥18 years, who underwent goniotomy from January 2021 to December 2022 with ≥3 months of follow-up. Primary outcomes were IOP spikes (≥10 mm Hg increase within 3 months) and 12-month surgical success (≥20% IOP and/or ≥1 medication reduction without further surgery). Secondary outcomes included IOP and medication changes.</p><p><strong>Results: </strong>Among 247 eyes (107 KDB, 63 OMNI, 77 BANG; all with phacoemulsification), IOP spikes occurred in 13.0% with no difference between groups (<i>p</i> = 0.900). Spikes were more common in severe glaucoma and associated with failure (<i>p</i> = 0.041), postoperative interventions (<i>p</i> <0.001), and reoperation (<i>p</i> = 0.026). At 12 months (<i>n</i> = 164), 68.9% achieved success with no difference between procedures (<i>p</i> = 0.972). Lower baseline IOP, open-angle glaucoma (OAG), and IOP spikes predicted failure. GATT eyes (<i>n</i> = 39, mostly standalone) had different baseline characteristics, were excluded from main analysis, but showed similar success (79.3%) with greater IOP and medication reduction.</p><p><strong>Conclusion: </strong>Kahook Dual Blade, OMNI, and BANG with phacoemulsification had comparable 1-year safety and efficacy. IOP spikes increase the risk of failure and reoperation, especially in severe glaucoma. GATT showed favorable outcomes when performed standalone.</p><p><strong>Clinical significance: </strong>Choice among KDB, OMNI, and BANG can be individualized without compromising outcomes. Monitoring for IOP spikes is crucial in high-risk eyes. Standalone GATT offers strong results when cataract surgery is not needed.</p><p><strong>How to cite this article: </strong>Shalaby WS, Chang SL, Yu J, <i>et al.</i> Impact of Postoperative Intraocular Pressure Spikes on Outcomes Following Goniotomy: A Comparative Study of Surgical Techniques. J Curr Glaucoma Pract 2025;19(4):186-198.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 4","pages":"186-198"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12780354/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145952031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-10-04DOI: 10.5005/jp-journals-10078-1491
Alexander T Hong, Susan H Kishi, Lucas Humayun, Jiun L Do, Brandon J Wong
Purpose: To evaluate the effect of sub-Tenon's triamcinolone acetonide (TA) on the hypertensive phase (HP) and postoperative outcomes in patients with neovascular glaucoma (NVG) after Ahmed glaucoma valve (AGV) surgery.
Methods: We conducted a retrospective review of 112 NVG patients (58 TA, 54 non-TA) who underwent AGV implantation with a 6-month follow-up. HP was defined as intraocular pressure (IOP) > 21 mm Hg within the first 3 months. Primary outcomes included IOP and HP occurrence. Secondary outcomes included complications, number of glaucoma drops, surgical failure, and visual acuity (VA).
Results: Non-TA patients were significantly more likely to develop HP (70 vs 50%, p = 0.03). Mean IOP (18.34 ± 7.96 vs 17.75 ± 6.16 mm Hg, p = 0.75), VA (1.46 ± 0.96 vs 1.32 ± 0.94 logMAR, p = 0.56), surgical failure (63 vs 48%, p = 0.13), rates of complication (9.3 vs 5.2%, p = 0.48), and number of glaucoma eye drops (2.59 ± 1.38 vs 2.18 ± 1.63, p = 0.29) were similar at 6 months. Compared to baseline, significant IOP reductions were observed in the TA group at month 1 (-24.62 ± 16.60 vs -18.43 ± 14.39 mm Hg, p = 0.05) and month 3 (-25.65 ± 14.05 vs -19.05 ± 13.14 mm Hg, p = 0.03).
Conclusion: Sub-Tenon's TA reduces the risk of HP and short-term IOP spikes in NVG patients undergoing AGV implantation but does not improve long-term IOP regulation, visual outcomes, or surgical success.
Clinical significance: Reducing HP may help prevent early postoperative complications, improving short-term management of NVG patients receiving AGV implants.
How to cite this article: Hong AT, Kishi SH, Humayun L, et al. Effect of Sub-Tenon's Triamcinolone on Hypertensive Phase and Clinical Outcomes Following Ahmed Glaucoma Valve Implantation in Neovascular Glaucoma Patients. J Curr Glaucoma Pract 2025;19(3):129-135.
目的:评价亚- tenon曲安奈德(TA)对Ahmed青光眼瓣膜(AGV)术后新生血管性青光眼(NVG)患者高血压期(HP)及术后预后的影响。方法:我们对112例接受AGV植入的NVG患者(58例TA, 54例非TA)进行了回顾性分析,随访6个月。HP的定义为前3个月内眼压(IOP)低于21 mm Hg。主要结局包括IOP和HP的发生。次要结果包括并发症、青光眼滴数、手术失败和视力(VA)。结果:非ta患者更容易发生HP (70% vs 50%, p = 0.03)。6个月时平均IOP(18.34±7.96 vs 17.75±6.16 mm Hg, p = 0.75)、VA(1.46±0.96 vs 1.32±0.94 logMAR, p = 0.56)、手术失败(63 vs 48%, p = 0.13)、并发症发生率(9.3 vs 5.2%, p = 0.48)、青光眼滴眼液次数(2.59±1.38 vs 2.18±1.63,p = 0.29)相似。与基线相比,TA组在第1个月(-24.62±16.60 vs -18.43±14.39 mm Hg, p = 0.05)和第3个月(-25.65±14.05 vs -19.05±13.14 mm Hg, p = 0.03)观察到明显的IOP降低。结论:Sub-Tenon的TA降低了接受AGV植入的NVG患者HP和短期IOP尖峰的风险,但没有改善长期IOP调节、视力结果或手术成功率。临床意义:降低HP有助于预防早期术后并发症,改善接受AGV植入的NVG患者的短期管理。本文引用方式:Hong AT, Kishi SH, Humayun L,等。亚tenon曲安奈德对新生血管性青光眼患者艾哈迈德青光眼瓣膜置入术后高血压期及临床疗效的影响。中华青光眼杂志(英文版);2015;19(3):129-135。
{"title":"Effect of Sub-Tenon's Triamcinolone on Hypertensive Phase and Clinical Outcomes Following Ahmed Glaucoma Valve Implantation in Neovascular Glaucoma Patients.","authors":"Alexander T Hong, Susan H Kishi, Lucas Humayun, Jiun L Do, Brandon J Wong","doi":"10.5005/jp-journals-10078-1491","DOIUrl":"10.5005/jp-journals-10078-1491","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the effect of sub-Tenon's triamcinolone acetonide (TA) on the hypertensive phase (HP) and postoperative outcomes in patients with neovascular glaucoma (NVG) after Ahmed glaucoma valve (AGV) surgery.</p><p><strong>Methods: </strong>We conducted a retrospective review of 112 NVG patients (58 TA, 54 non-TA) who underwent AGV implantation with a 6-month follow-up. HP was defined as intraocular pressure (IOP) > 21 mm Hg within the first 3 months. Primary outcomes included IOP and HP occurrence. Secondary outcomes included complications, number of glaucoma drops, surgical failure, and visual acuity (VA).</p><p><strong>Results: </strong>Non-TA patients were significantly more likely to develop HP (70 vs 50%, <i>p</i> = 0.03). Mean IOP (18.34 ± 7.96 vs 17.75 ± 6.16 mm Hg, <i>p</i> = 0.75), VA (1.46 ± 0.96 vs 1.32 ± 0.94 logMAR, <i>p</i> = 0.56), surgical failure (63 vs 48%, <i>p</i> = 0.13), rates of complication (9.3 vs 5.2%, <i>p</i> = 0.48), and number of glaucoma eye drops (2.59 ± 1.38 vs 2.18 ± 1.63, <i>p</i> = 0.29) were similar at 6 months. Compared to baseline, significant IOP reductions were observed in the TA group at month 1 (-24.62 ± 16.60 vs -18.43 ± 14.39 mm Hg, <i>p</i> = 0.05) and month 3 (-25.65 ± 14.05 vs -19.05 ± 13.14 mm Hg, <i>p</i> = 0.03).</p><p><strong>Conclusion: </strong>Sub-Tenon's TA reduces the risk of HP and short-term IOP spikes in NVG patients undergoing AGV implantation but does not improve long-term IOP regulation, visual outcomes, or surgical success.</p><p><strong>Clinical significance: </strong>Reducing HP may help prevent early postoperative complications, improving short-term management of NVG patients receiving AGV implants.</p><p><strong>How to cite this article: </strong>Hong AT, Kishi SH, Humayun L, <i>et al.</i> Effect of Sub-Tenon's Triamcinolone on Hypertensive Phase and Clinical Outcomes Following Ahmed Glaucoma Valve Implantation in Neovascular Glaucoma Patients. J Curr Glaucoma Pract 2025;19(3):129-135.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 3","pages":"129-135"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12533712/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-10-04DOI: 10.5005/jp-journals-10078-1488
Simon Ondrejka, Norbert Koerber
Purpose: To investigate outcomes of interventional glaucoma therapy with canaloplasty in early glaucoma.
Methods: This retrospective single-center study included patients with mild-to-moderate open-angle glaucoma (OAG) who underwent Ab-interno canaloplasty (ABiC) with iTrack Advance (Nova Eye Medical) with or without combined phacoemulsification. Primary outcomes were intraocular pressure (IOP) and glaucoma medications at 12-, 24-month, and last follow-up (LFU) visits. Secondary outcomes included the proportion of eyes reaching target IOPs, requiring no medications, and achieving success as per American Academy of Ophthalmology (AAO) criteria.
Results: Ninety-eight eyes (60 patients, mean age: 71.4 ± 7.0 years) were included, with a mean follow-up of 19.0 ± 5.7 months. Mean IOP (mm Hg) reduced from 18.3 ± 4.3 at baseline (n = 98) to 14.2 ± 3.1 at 12 months (n = 93), 14.1 ± 3.3 at 24 months (n = 67), and 14.6 ± 3.2 at LFU (p < 0.001). Mean medications decreased from 1.9 ± 0.8 at baseline to 0.1 ± 0.5 at both 12 and 24 months, and 0.1 ± 0.4 at LFU, respectively (p < 0.001). At LFU, 89% of eyes achieved IOP ≤ 18 mm Hg, while 95% were medication-free compared to none at baseline. Success rates following combined canaloplasty and phacoemulsification (n = 90) and stand-alone canaloplasty (n = 8) were 81% and 50%, respectively. The average visual field mean deviation at baseline was -1.90 ± 2.8 dB, which remained stable at LFU (p = 0.439). The postoperative complication was a transient IOP spike (≥30 mm Hg) in two eyes. No sight-threatening complications were observed, and no additional glaucoma procedures were required.
Conclusion: Interventional treatment with iTrack Advance canaloplasty in early OAG showed high safety and achieved IOP control, with near-elimination of medication dependence sustained over 24 months postoperatively.
Clinical significance: iTrack Advance canaloplasty provides sustained IOP control and strong medication reduction in the medium term.
How to cite this article: Ondrejka S, Koerber N. The Impact of Interventional Glaucoma with and without Cataract Surgery in Early Open-angle Glaucoma: 24-month Results with a New Canaloplasty Device. J Curr Glaucoma Pract 2025;19(3):112-118.
{"title":"The Impact of Interventional Glaucoma with and without Cataract Surgery in Early Open-angle Glaucoma: 24-month Results with a New Canaloplasty Device.","authors":"Simon Ondrejka, Norbert Koerber","doi":"10.5005/jp-journals-10078-1488","DOIUrl":"10.5005/jp-journals-10078-1488","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate outcomes of interventional glaucoma therapy with canaloplasty in early glaucoma.</p><p><strong>Methods: </strong>This retrospective single-center study included patients with mild-to-moderate open-angle glaucoma (OAG) who underwent Ab-interno canaloplasty (ABiC) with iTrack Advance (Nova Eye Medical) with or without combined phacoemulsification. Primary outcomes were intraocular pressure (IOP) and glaucoma medications at 12-, 24-month, and last follow-up (LFU) visits. Secondary outcomes included the proportion of eyes reaching target IOPs, requiring no medications, and achieving success as per American Academy of Ophthalmology (AAO) criteria.</p><p><strong>Results: </strong>Ninety-eight eyes (60 patients, mean age: 71.4 ± 7.0 years) were included, with a mean follow-up of 19.0 ± 5.7 months. Mean IOP (mm Hg) reduced from 18.3 ± 4.3 at baseline (<i>n</i> = 98) to 14.2 ± 3.1 at 12 months (<i>n</i> = 93), 14.1 ± 3.3 at 24 months (<i>n</i> = 67), and 14.6 ± 3.2 at LFU (<i>p</i> < 0.001). Mean medications decreased from 1.9 ± 0.8 at baseline to 0.1 ± 0.5 at both 12 and 24 months, and 0.1 ± 0.4 at LFU, respectively (<i>p</i> < 0.001). At LFU, 89% of eyes achieved IOP ≤ 18 mm Hg, while 95% were medication-free compared to none at baseline. Success rates following combined canaloplasty and phacoemulsification (<i>n</i> = 90) and stand-alone canaloplasty (<i>n</i> = 8) were 81% and 50%, respectively. The average visual field mean deviation at baseline was -1.90 ± 2.8 dB, which remained stable at LFU (<i>p</i> = 0.439). The postoperative complication was a transient IOP spike (≥30 mm Hg) in two eyes. No sight-threatening complications were observed, and no additional glaucoma procedures were required.</p><p><strong>Conclusion: </strong>Interventional treatment with iTrack Advance canaloplasty in early OAG showed high safety and achieved IOP control, with near-elimination of medication dependence sustained over 24 months postoperatively.</p><p><strong>Clinical significance: </strong>iTrack Advance canaloplasty provides sustained IOP control and strong medication reduction in the medium term.</p><p><strong>How to cite this article: </strong>Ondrejka S, Koerber N. The Impact of Interventional Glaucoma with and without Cataract Surgery in Early Open-angle Glaucoma: 24-month Results with a New Canaloplasty Device. J Curr Glaucoma Pract 2025;19(3):112-118.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 3","pages":"112-118"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12533722/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-10-04DOI: 10.5005/jp-journals-10078-1492
Raden Maula Rifada, Lina Shabrina Qorib, Iffa Nadifa Riza Hardjasasmita, Andika Prahasta Gandasubrata, Sonie Umbara, Elsa Gustianty
Aims and background: The aim of this study is to compare and assess the correlation of retinal nerve fiber layer (RNFL) thickness, peripapillary retinal perfusion density, and flux index in primary open-angle glaucoma (POAG) patients and healthy eyes.
Materials and methods: This cross-sectional study analyzed 53 eyes of POAG patients and 56 eyes of healthy individuals. The peripapillary perfusion density and flux index were measured using optical coherence tomography angiography (OCTA), while the RNFL thickness was evaluated using Cirrus optical coherence tomography (OCT).
Results: In POAG patients, peripapillary retinal perfusion density significantly decreased in the superior, inferior, nasal, and total quadrants compared to healthy individuals (p = 0.0001), but no difference in the temporal quadrant (p = 0.670). The peripapillary retinal flux index also showed a significant reduction across all quadrants in the POAG group compared to healthy eyes (p = 0.0001). RNFL was significantly thinner in POAG patients than in healthy eyes (p = 0.0001 in the superior, inferior, nasal, and total RNFL; p = 0.017 in the temporal quadrant). A moderate to strong correlation was observed between peripapillary retinal perfusion density, flux index, and RNFL thickness in POAG subjects.
Conclusion: Decreased peripapillary retinal perfusion density and flux index have significant associations with RNFL thickness in POAG patients, indicating the role of peripapillary perfusion changes in RNFL thinning. This highlights the importance of including vascular assessments in POAG diagnostics and management.
Clinical significance: This study highlights the value of noninvasive diagnostic tools such as OCT and OCTA to assess both structural and vascular changes in glaucoma. This approach could help to detect POAG at an earlier stage, allowing for timely intervention to slow the disease progression.
How to cite this article: Rifada RM, Qorib LS, Riza Hardjasasmita IN, et al. Exploring Ocular Perfusion and Structural Alterations of POAG in Indonesia: Insights from OCTA and OCT Analysis. J Curr Glaucoma Pract 2025;19(3):136-142.
目的与背景:本研究的目的是比较和评估原发性开角型青光眼(POAG)患者与健康眼视网膜神经纤维层(RNFL)厚度、乳头状周围视网膜灌注密度和通量指数的相关性。材料和方法:本横断面研究分析了53只POAG患者和56只健康人的眼睛。采用光学相干断层扫描血管造影(OCTA)测量乳头周围灌注密度和通量指数,使用Cirrus光学相干断层扫描(OCT)评估RNFL厚度。结果:POAG患者乳头周围视网膜灌注密度在上、下、鼻和总象限与健康个体相比显著降低(p = 0.0001),但在颞象限无差异(p = 0.670)。与健康眼睛相比,POAG组的乳头周围视网膜通量指数在所有象限上也显着降低(p = 0.0001)。POAG患者的RNFL明显比健康眼薄(上、下、鼻和全RNFL p = 0.0001;颞象限p = 0.017)。在POAG受试者中,观察到乳头周围视网膜灌注密度、通量指数和RNFL厚度之间存在中等到强的相关性。结论:POAG患者乳头周围视网膜灌注密度和通量指数下降与RNFL厚度有显著相关性,提示乳头周围灌注改变在RNFL变薄中的作用。这突出了在POAG诊断和管理中纳入血管评估的重要性。临床意义:本研究强调了OCT和OCTA等无创诊断工具在评估青光眼结构和血管变化方面的价值。这种方法可以帮助在早期阶段检测POAG,从而允许及时干预以减缓疾病进展。如何引用本文:Rifada RM, Qorib LS, Riza Hardjasasmita IN等。探索印尼POAG眼灌注和结构改变:来自OCTA和OCT分析的见解。中华青光眼杂志(英文版);2009;19(3):391 - 391。
{"title":"Exploring Ocular Perfusion and Structural Alterations of POAG in Indonesia: Insights from OCTA and OCT Analysis.","authors":"Raden Maula Rifada, Lina Shabrina Qorib, Iffa Nadifa Riza Hardjasasmita, Andika Prahasta Gandasubrata, Sonie Umbara, Elsa Gustianty","doi":"10.5005/jp-journals-10078-1492","DOIUrl":"10.5005/jp-journals-10078-1492","url":null,"abstract":"<p><strong>Aims and background: </strong>The aim of this study is to compare and assess the correlation of retinal nerve fiber layer (RNFL) thickness, peripapillary retinal perfusion density, and flux index in primary open-angle glaucoma (POAG) patients and healthy eyes.</p><p><strong>Materials and methods: </strong>This cross-sectional study analyzed 53 eyes of POAG patients and 56 eyes of healthy individuals. The peripapillary perfusion density and flux index were measured using optical coherence tomography angiography (OCTA), while the RNFL thickness was evaluated using Cirrus optical coherence tomography (OCT).</p><p><strong>Results: </strong>In POAG patients, peripapillary retinal perfusion density significantly decreased in the superior, inferior, nasal, and total quadrants compared to healthy individuals (<i>p</i> = 0.0001), but no difference in the temporal quadrant (<i>p</i> = 0.670). The peripapillary retinal flux index also showed a significant reduction across all quadrants in the POAG group compared to healthy eyes (<i>p</i> = 0.0001). RNFL was significantly thinner in POAG patients than in healthy eyes (<i>p</i> = 0.0001 in the superior, inferior, nasal, and total RNFL; <i>p</i> = 0.017 in the temporal quadrant). A moderate to strong correlation was observed between peripapillary retinal perfusion density, flux index, and RNFL thickness in POAG subjects.</p><p><strong>Conclusion: </strong>Decreased peripapillary retinal perfusion density and flux index have significant associations with RNFL thickness in POAG patients, indicating the role of peripapillary perfusion changes in RNFL thinning. This highlights the importance of including vascular assessments in POAG diagnostics and management.</p><p><strong>Clinical significance: </strong>This study highlights the value of noninvasive diagnostic tools such as OCT and OCTA to assess both structural and vascular changes in glaucoma. This approach could help to detect POAG at an earlier stage, allowing for timely intervention to slow the disease progression.</p><p><strong>How to cite this article: </strong>Rifada RM, Qorib LS, Riza Hardjasasmita IN, <i>et al.</i> Exploring Ocular Perfusion and Structural Alterations of POAG in Indonesia: Insights from OCTA and OCT Analysis. J Curr Glaucoma Pract 2025;19(3):136-142.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 3","pages":"136-142"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12533724/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A cyclodialysis cleft develops when the meridional fibers of the ciliary muscle detach from the scleral spur, creating an aberrant aqueous drainage pathway between the anterior chamber and suprachoroidal space. Blunt ocular trauma and intraocular surgery have been identified as the most frequent causes. Cyclodialysis has been documented after phacoemulsification, extracapsular cataract extraction, secondary intraocular lens (IOL) implantation, goniotomy, trabeculotomy, trabeculectomy, and other intraocular surgeries. The new aqueous drainage pathway may lead to persistent severe ocular hypotony and its associated complications, which include cataract, choroidal detachment, retinochoroidal folds, disk edema, macular edema, and rarely, irreversible vision loss. The potentially blinding nature of this condition warrants early identification and appropriate management. Restoration of the attachment of the ciliary body (CB) to the sclera and closure of the cleft are the primary objectives of treatment. The etiology, pathophysiology, and surgical treatment of cyclodialysis cleft are discussed in this review.
How to cite this article: Sethi A, Udenia H, Beri N, et al. Surgical Management of Cyclodialysis Cleft: An Update. J Curr Glaucoma Pract 2025;19(3):143-152.
睫状肌的子午纤维与巩膜骨刺分离,在前房和脉络膜上间隙之间形成异常的水引流通道,形成睫状膜裂。钝性眼外伤和眼内手术被认为是最常见的原因。在超声乳化术、白内障囊外摘除术、继发性人工晶状体植入术、性腺切开术、小梁切开术、小梁切除术和其他眼内手术后均有睫状体透析的记录。新的水引流途径可能导致持续严重的低眼压及其相关并发症,包括白内障、脉络膜脱离、视网膜脉络膜褶皱、椎间盘水肿、黄斑水肿,以及罕见的不可逆视力丧失。这种情况的潜在致盲性质需要早期识别和适当的管理。睫状体(CB)附着于巩膜的修复和腭裂的闭合是治疗的主要目的。本文就睫状体裂的病因、病理生理及手术治疗作一综述。如何引用本文:Sethi A, Udenia H, Beri N等。睫状体透析裂的外科治疗:最新进展。中华青光眼杂志,2015;19(3):143-152。
{"title":"Surgical Management of Cyclodialysis Cleft: An Update.","authors":"Anin Sethi, Hemlata Udenia, Nitika Beri, Dewang Angmo, Aafreen Bari, Namrata Sharma, Tanuj Dada","doi":"10.5005/jp-journals-10078-1469","DOIUrl":"10.5005/jp-journals-10078-1469","url":null,"abstract":"<p><p>A cyclodialysis cleft develops when the meridional fibers of the ciliary muscle detach from the scleral spur, creating an aberrant aqueous drainage pathway between the anterior chamber and suprachoroidal space. Blunt ocular trauma and intraocular surgery have been identified as the most frequent causes. Cyclodialysis has been documented after phacoemulsification, extracapsular cataract extraction, secondary intraocular lens (IOL) implantation, goniotomy, trabeculotomy, trabeculectomy, and other intraocular surgeries. The new aqueous drainage pathway may lead to persistent severe ocular hypotony and its associated complications, which include cataract, choroidal detachment, retinochoroidal folds, disk edema, macular edema, and rarely, irreversible vision loss. The potentially blinding nature of this condition warrants early identification and appropriate management. Restoration of the attachment of the ciliary body (CB) to the sclera and closure of the cleft are the primary objectives of treatment. The etiology, pathophysiology, and surgical treatment of cyclodialysis cleft are discussed in this review.</p><p><strong>How to cite this article: </strong>Sethi A, Udenia H, Beri N, <i>et al.</i> Surgical Management of Cyclodialysis Cleft: An Update. J Curr Glaucoma Pract 2025;19(3):143-152.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 3","pages":"143-152"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12533715/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01DOI: 10.5005/jp-journals-10078-1489
Shibal Bhartiya, Xiulan Zhang, Shamira Perera
{"title":"Minimally Invasive Glaucoma Surgeries, Health Economics, and the Moral Imperative of Equity in Glaucoma Care.","authors":"Shibal Bhartiya, Xiulan Zhang, Shamira Perera","doi":"10.5005/jp-journals-10078-1489","DOIUrl":"10.5005/jp-journals-10078-1489","url":null,"abstract":"","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 3","pages":"103-106"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12533714/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01DOI: 10.5005/jp-journals-10078-1475
Arthur J Sit, Carol B Toris, Vikas Gulati, Arash Kazemi, David M Reed, Sayoko E Moroi
{"title":"Re: Di Staso and Gaudio-Aqueous Outflow Facility after Periocular Triamcinolone Injection: A Preliminary Evaluation of the Falck Medical Applanation Tonometer.","authors":"Arthur J Sit, Carol B Toris, Vikas Gulati, Arash Kazemi, David M Reed, Sayoko E Moroi","doi":"10.5005/jp-journals-10078-1475","DOIUrl":"10.5005/jp-journals-10078-1475","url":null,"abstract":"","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 3","pages":"153-154"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12533713/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-10-04DOI: 10.5005/jp-journals-10078-1476
Manish Taywade, Bhagabat Nayak, Debkumar Pal, Sampath Kumar Enubothula, Koyel Chakraborty, Kajal Das, Binod K Patro, Priyamadhaba Behera
Background and objectives: Early diagnosis of glaucoma is one of the most crucial strategies to tackle the huge burden of glaucoma and associated blindness. Early diagnosis, though, will not cure the disease but prevent the progression of glaucoma, leading to a reduction in ocular morbidity. This study aimed to estimate the proportion of the population with knowledge of glaucoma and their attitude and practices related to the disease.
Materials and methods: We conducted this community-based cross-sectional study in Mendhasala, a rural block of Odisha, a state in eastern India. We chose two of the five sectors in the block using simple random sampling. We employed a 30 × 30 cluster sampling method, selecting 30 participants from each village. Households with at least one member over 18 were identified using systematic random sampling. The data were collected using a prestructured and validated questionnaire and analyzed using Microsoft Excel 2021.
Results: We gathered data from 899 participants, containing sociodemographic information and information about their knowledge, attitudes, and practices concerning glaucoma. The mean age of the participants was 45.7 years (SD 14.43), with an almost equal number of males and females. Only 4.23% (95% CI: 3.01%-5.8%) had ever heard of glaucoma, of whom three were unaware of the eye changes associated with the condition. Education and employment status were significant predictors of knowledge related to glaucoma.
Conclusion: Health education campaigns should be reinforced at the community level to increase the knowledge related to glaucoma. This may increase the care-seeking attitude towards glaucoma in the community.
How to cite this article: Taywade M, Nayak B, Pal D, et al. Knowledge, Attitude, and Practices Related to Glaucoma in a Rural Population of Eastern India: A Cross-sectional Study. J Curr Glaucoma Pract 2025;19(3):119-124.
{"title":"Knowledge, Attitude, and Practices Related to Glaucoma in a Rural Population of Eastern India: A Cross-sectional Study.","authors":"Manish Taywade, Bhagabat Nayak, Debkumar Pal, Sampath Kumar Enubothula, Koyel Chakraborty, Kajal Das, Binod K Patro, Priyamadhaba Behera","doi":"10.5005/jp-journals-10078-1476","DOIUrl":"10.5005/jp-journals-10078-1476","url":null,"abstract":"<p><strong>Background and objectives: </strong>Early diagnosis of glaucoma is one of the most crucial strategies to tackle the huge burden of glaucoma and associated blindness. Early diagnosis, though, will not cure the disease but prevent the progression of glaucoma, leading to a reduction in ocular morbidity. This study aimed to estimate the proportion of the population with knowledge of glaucoma and their attitude and practices related to the disease.</p><p><strong>Materials and methods: </strong>We conducted this community-based cross-sectional study in Mendhasala, a rural block of Odisha, a state in eastern India. We chose two of the five sectors in the block using simple random sampling. We employed a 30 × 30 cluster sampling method, selecting 30 participants from each village. Households with at least one member over 18 were identified using systematic random sampling. The data were collected using a prestructured and validated questionnaire and analyzed using Microsoft Excel 2021.</p><p><strong>Results: </strong>We gathered data from 899 participants, containing sociodemographic information and information about their knowledge, attitudes, and practices concerning glaucoma. The mean age of the participants was 45.7 years (SD 14.43), with an almost equal number of males and females. Only 4.23% (95% CI: 3.01%-5.8%) had ever heard of glaucoma, of whom three were unaware of the eye changes associated with the condition. Education and employment status were significant predictors of knowledge related to glaucoma.</p><p><strong>Conclusion: </strong>Health education campaigns should be reinforced at the community level to increase the knowledge related to glaucoma. This may increase the care-seeking attitude towards glaucoma in the community.</p><p><strong>How to cite this article: </strong>Taywade M, Nayak B, Pal D, <i>et al.</i> Knowledge, Attitude, and Practices Related to Glaucoma in a Rural Population of Eastern India: A Cross-sectional Study. J Curr Glaucoma Pract 2025;19(3):119-124.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 3","pages":"119-124"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12533723/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aim and background: Glaucoma is a leading cause of blindness in India, and treatment adherence is essential to prevent vision loss. However, studies have shown that treatment adherence rates among glaucoma patients in India are low. It is important to identify the factors determining treatment adherence in order to improve compliance with the treatment, thereby preventing worsening vision. The current study was conducted with an objective to assess the treatment adherence among glaucoma patients using the Morisky Medication Adherence Scale (MMAS-8) and to assess determinants of treatment adherence among the study participants. A drop instillation technique among the glaucoma patients was also evaluated.
Materials and methods: A cross-sectional study was conducted among primary open-angle glaucoma (POAG) patients at a selected tertiary care institute in Ahmedabad city. The calculated sample size was 100. Glaucoma patients receiving treatment for at least 3 months were enrolled. Systematic sampling was applied, wherein every alternate patient fulfilling the inclusion criteria was selected. After obtaining informed consent, interviews were conducted using a pretested and predesigned pro forma including MMAS-8. Participants were instructed to use sterile artificial tears, which were evaluated by the investigator for precision.
Results: The mean age of study participants was 62.0 ± 6.28 years. Among the participants, 54% were female. The study revealed that 82% of participants had poor adherence to glaucoma medication. Factors such as education, regular follow-up, and having received prior instruction were significantly associated with adherence to medications. Only 43% of the patients were able to instill the eye drops correctly.
Conclusion: Low adherence to medication was found among 82% of cases. Factors significantly associated with adherence were gender, education, duration of treatment, and having received prior instruction. Forgetfulness and the cost of treatment were the most common factors leading to low treatment adherence. Among 79 participants who were observed for the drop instillation technique, 43% were found to have instilled it properly.
How to cite this article: Shah V, Shah D, Desai HP, et al. A Cross-sectional Study on Adherence to Topical Glaucoma Medication and its Determinants among Patients Attending Glaucoma Clinics of a Tertiary Care Institute of Ahmedabad City, Gujarat, India. J Curr Glaucoma Pract 2025;19(3):107-111.
目的和背景:青光眼是印度致盲的主要原因,坚持治疗对于预防视力丧失至关重要。然而,研究表明,印度青光眼患者的治疗依从率很低。为了提高治疗依从性,从而防止视力恶化,确定决定治疗依从性的因素是很重要的。本研究的目的是使用Morisky药物依从性量表(MMAS-8)评估青光眼患者的治疗依从性,并评估研究参与者中治疗依从性的决定因素。对青光眼患者滴注技术也进行了评价。材料和方法:在艾哈迈达巴德市选定的一家三级保健机构对原发性开角型青光眼(POAG)患者进行了横断面研究。计算的样本量为100。接受治疗至少3个月的青光眼患者被纳入研究。采用系统抽样,其中选择每个符合纳入标准的替代患者。在获得知情同意后,使用预先测试和预先设计的表格(包括MMAS-8)进行访谈。参与者被指示使用无菌人工泪液,研究者对其精度进行了评估。结果:研究参与者的平均年龄为62.0±6.28岁。在参与者中,54%是女性。研究显示,82%的参与者对青光眼药物的依从性较差。教育、定期随访和接受过事先指导等因素与药物依从性显著相关。只有43%的患者能够正确滴入眼药水。结论:82%的患者对药物的依从性较低。与依从性显著相关的因素是性别、教育程度、治疗持续时间和是否接受过先前的指导。健忘和治疗费用是导致治疗依从性低的最常见因素。在79名被观察滴注技术的参与者中,43%的人被发现正确滴注。如何引用本文:Shah V, Shah D, Desai HP等。印度古吉拉特邦艾哈迈达巴德市三级保健研究所青光眼门诊患者对局部青光眼药物依从性及其决定因素的横断面研究中华实用青光眼杂志,2015;19(3):107-111。
{"title":"A Cross-sectional Study on Adherence to Topical Glaucoma Medication and its Determinants among Patients Attending Glaucoma Clinics of a Tertiary Care Institute of Ahmedabad City, Gujarat, India.","authors":"Venu Shah, Drashti Shah, Hemaxi P Desai, Rakesh Bamania, Monika Upadhyay","doi":"10.5005/jp-journals-10078-1479","DOIUrl":"10.5005/jp-journals-10078-1479","url":null,"abstract":"<p><strong>Aim and background: </strong>Glaucoma is a leading cause of blindness in India, and treatment adherence is essential to prevent vision loss. However, studies have shown that treatment adherence rates among glaucoma patients in India are low. It is important to identify the factors determining treatment adherence in order to improve compliance with the treatment, thereby preventing worsening vision. The current study was conducted with an objective to assess the treatment adherence among glaucoma patients using the Morisky Medication Adherence Scale (MMAS-8) and to assess determinants of treatment adherence among the study participants. A drop instillation technique among the glaucoma patients was also evaluated.</p><p><strong>Materials and methods: </strong>A cross-sectional study was conducted among primary open-angle glaucoma (POAG) patients at a selected tertiary care institute in Ahmedabad city. The calculated sample size was 100. Glaucoma patients receiving treatment for at least 3 months were enrolled. Systematic sampling was applied, wherein every alternate patient fulfilling the inclusion criteria was selected. After obtaining informed consent, interviews were conducted using a pretested and predesigned pro forma including MMAS-8. Participants were instructed to use sterile artificial tears, which were evaluated by the investigator for precision.</p><p><strong>Results: </strong>The mean age of study participants was 62.0 ± 6.28 years. Among the participants, 54% were female. The study revealed that 82% of participants had poor adherence to glaucoma medication. Factors such as education, regular follow-up, and having received prior instruction were significantly associated with adherence to medications. Only 43% of the patients were able to instill the eye drops correctly.</p><p><strong>Conclusion: </strong>Low adherence to medication was found among 82% of cases. Factors significantly associated with adherence were gender, education, duration of treatment, and having received prior instruction. Forgetfulness and the cost of treatment were the most common factors leading to low treatment adherence. Among 79 participants who were observed for the drop instillation technique, 43% were found to have instilled it properly.</p><p><strong>How to cite this article: </strong>Shah V, Shah D, Desai HP, <i>et al.</i> A Cross-sectional Study on Adherence to Topical Glaucoma Medication and its Determinants among Patients Attending Glaucoma Clinics of a Tertiary Care Institute of Ahmedabad City, Gujarat, India. J Curr Glaucoma Pract 2025;19(3):107-111.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 3","pages":"107-111"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12533721/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01Epub Date: 2025-10-04DOI: 10.5005/jp-journals-10078-1490
Sarah Atta, Ang Li
Aim and background: The XEN Gel Implant is a microstent, which aims to lower intraocular pressure by forming a subconjunctival bleb to drain aqueous. The aim of this study is to assess the IOP-lowering effects of a novel trimming surgical technique, which shortens the length of the XEN Gel Stent.
Materials and methods: Patients who underwent placement of an XEN Gel Stent using the novel primary trimming technique from 10/2020 to 6/2023 were included for chart review. The technique includes an intentional trimming of the XEN about 1 mm prior to ab interno placement. Outcomes included intraocular pressure (preoperative, postoperative month 1, postoperative month 6, postoperative year 1) as well as the number of glaucoma drops. Statistical analysis was performed to assess for differences between preoperative and postoperative outcomes.
Results: Thirty cases were included. The average age of patients was 73.3 ± 11.7 years. The average preoperative IOP was 19.9 ± 5.8 mm Hg. The average number of preoperative glaucoma drops was 2.6 ± 1.2. The average IOP at postoperative month 1 (14.0 ± 5.7 mm Hg), postoperative month 6 (13.8 ± 7.6 mm Hg), and postoperative year 1 (13.3 ± 8.0 mm Hg) were all significantly lower than preoperative IOP (p < 0.01). The average number of glaucoma drops at year 1 was 1.5 ± 1.2 and significantly lower than the number of preoperative glaucoma drops (p < 0.01). Postoperative complications included in-office bleb needling (33.3%), IOP spike (20%), hypotony (10%), and cystoid macular edema (3.3%). No cases had conjunctival erosion.
Conclusion: This surgical trimming technique for the XEN Gel Stent showed significant reductions in IOP at postoperative month 1, month 6, and year 1, as well as the need for fewer postoperative glaucoma drops for adequate control.
Clinical significance: This novel technique effectively lowers IOP among patients with a low IOP goal while maintaining a safety profile comparable to standard methods.
How to cite this article: Atta S, Li A. Intraocular Pressure and Medication Outcomes of a Novel Primary Trimming Technique for XEN Gel Stent. J Curr Glaucoma Pract 2025;19(3):125-128.
目的和背景:XEN凝胶植入物是一种微支架,其目的是通过形成结膜下泡来排出水来降低眼压。本研究的目的是评估一种新颖的修剪手术技术降低眼压的效果,该技术缩短了XEN凝胶支架的长度。材料和方法:纳入2020年10月至2023年6月期间使用新型初级修剪技术放置XEN凝胶支架的患者进行图表回顾。该技术包括在插入前有意修剪XEN约1mm。结果包括眼压(术前、术后1个月、术后6个月、术后1年)和青光眼滴数。统计分析术前和术后结果的差异。结果:共纳入30例。患者平均年龄73.3±11.7岁。术前平均IOP为19.9±5.8 mm Hg,青光眼滴数为2.6±1.2。术后第1个月(14.0±5.7 mm Hg)、第6个月(13.8±7.6 mm Hg)、术后第1年(13.3±8.0 mm Hg)的平均IOP均显著低于术前(p < 0.01)。术后1年平均青光眼滴数为1.5±1.2,显著低于术前(p < 0.01)。术后并发症包括办公室内泡针(33.3%)、IOP尖峰(20%)、低眼压(10%)和黄斑囊样水肿(3.3%)。无结膜糜烂。结论:这种XEN凝胶支架的手术修剪技术在术后第1个月、第6个月和第1年的IOP显著降低,并且需要更少的术后青光眼滴眼液来充分控制。临床意义:这项新技术有效降低IOP目标低的患者的IOP,同时保持与标准方法相当的安全性。Atta S, Li a .一种新型XEN凝胶支架初级修剪技术的眼压和用药效果。中华青光眼杂志(英文版);2015;19(3):125-128。
{"title":"Intraocular Pressure and Medication Outcomes of a Novel Primary Trimming Technique for XEN Gel Stent.","authors":"Sarah Atta, Ang Li","doi":"10.5005/jp-journals-10078-1490","DOIUrl":"10.5005/jp-journals-10078-1490","url":null,"abstract":"<p><strong>Aim and background: </strong>The XEN Gel Implant is a microstent, which aims to lower intraocular pressure by forming a subconjunctival bleb to drain aqueous. The aim of this study is to assess the IOP-lowering effects of a novel trimming surgical technique, which shortens the length of the XEN Gel Stent.</p><p><strong>Materials and methods: </strong>Patients who underwent placement of an XEN Gel Stent using the novel primary trimming technique from 10/2020 to 6/2023 were included for chart review. The technique includes an intentional trimming of the XEN about 1 mm prior to <i>ab interno</i> placement. Outcomes included intraocular pressure (preoperative, postoperative month 1, postoperative month 6, postoperative year 1) as well as the number of glaucoma drops. Statistical analysis was performed to assess for differences between preoperative and postoperative outcomes.</p><p><strong>Results: </strong>Thirty cases were included. The average age of patients was 73.3 ± 11.7 years. The average preoperative IOP was 19.9 ± 5.8 mm Hg. The average number of preoperative glaucoma drops was 2.6 ± 1.2. The average IOP at postoperative month 1 (14.0 ± 5.7 mm Hg), postoperative month 6 (13.8 ± 7.6 mm Hg), and postoperative year 1 (13.3 ± 8.0 mm Hg) were all significantly lower than preoperative IOP (<i>p</i> < 0.01). The average number of glaucoma drops at year 1 was 1.5 ± 1.2 and significantly lower than the number of preoperative glaucoma drops (<i>p</i> < 0.01). Postoperative complications included in-office bleb needling (33.3%), IOP spike (20%), hypotony (10%), and cystoid macular edema (3.3%). No cases had conjunctival erosion.</p><p><strong>Conclusion: </strong>This surgical trimming technique for the XEN Gel Stent showed significant reductions in IOP at postoperative month 1, month 6, and year 1, as well as the need for fewer postoperative glaucoma drops for adequate control.</p><p><strong>Clinical significance: </strong>This novel technique effectively lowers IOP among patients with a low IOP goal while maintaining a safety profile comparable to standard methods.</p><p><strong>How to cite this article: </strong>Atta S, Li A. Intraocular Pressure and Medication Outcomes of a Novel Primary Trimming Technique for XEN Gel Stent. J Curr Glaucoma Pract 2025;19(3):125-128.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"19 3","pages":"125-128"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12533720/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}